SK bioscience
KOSE:A302440
42.000,00
₩-150,00 (-0,36%)
42.000,00
₩-150,00 (-0,36%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩-698,00
Earnings Per Share
₩3,41k
Revenue Per Share
11,24%
Gross Margin %
₩3.306,02 B
Market Cap
₩383,33 B
Long-Term Debt
Earnings Per Share
₩-698,00
Revenue Per Share
₩3,41k
Gross Margin %
11,24%
Market Cap
₩3.306,02 B
Long-Term Debt
₩383,33 B

Financials

Year Year 2024 2023 2022 2021
EPS Earnings Per Share ₩-698,00 ₩290,00 ₩1,59k ₩4,81k
Earnings Earnings ₩-54,69B ₩22,28B ₩122,08B ₩367,97B
RPS Revenue Per Share ₩3,41k ₩4,81k ₩5,95k ₩12,14k
Revenue Revenue ₩267,55B ₩369,51B ₩456,73B ₩929,00B
OCF Operating Cash Flow ₩-128,02B ₩29,35B ₩-124,96B ₩536,59B
FCF Free Cash Flow ₩-300,24B ₩-14,09B ₩-197,95B ₩493,69B
OM Operating Margin -51,74% -3,24% 25,18% 51,05%
GM % Gross Margin % 11,24% 38,38% 52,39% 61,36%
FCFS Free Cash Flow Per Share ₩-3.889,11 ₩-272,82 ₩-2.625,90 ₩6,71k
LT Debt Long-Term Debt ₩383,33B N/A N/A ₩35,50B
Sha. Stocks 78,35M 76,83M 76,78M 76,5M
×